Clare G Arnott

49PUBLICATIONS
149CO-AUTHORS
PharmacogenomicsSport and exercise nutritionPharmaceutical delivery technologiesRespiratory diseasesElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 04, 2026
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

|Aug 04, 2026
Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD.

|Jul 28, 2026
Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020-2025.

|Jun 24, 2026
Regional fat distribution as a determinant of mortality in populations with left ventricular systolic dysfunction: challenging the obesity paradox.

|Apr 02, 2026
Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition.

Erik Moedt, Akihiko Koshino, Niels Jongs

|Nov 11, 2025
Baseline Risk and Longitudinal Changes in kidneyintelX.dkd and Its Association With Kidney Outcomes in the CANVAS and CREDENCE Trials.

Erik Moedt, Steven G Coca, Katherine Edwards

Pageof 9

Frequent Collaborators

30 joint publications

Brendon L Neuen

27 joint publications

Hiddo Jl Heerspink

18 joint publications

Bruce Neal

8 joint publications

Rajiv Agarwal